CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 31 enrolled
Drug / intervention
Methadone +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01804075
NCT01804075Phase 4Completed
CompareCT.gov

Evaluation of Efficacy of Methadone Versus Morphine for Treatment of Neonatal Abstinence Syndrome (NAS).

Eastern Maine Medical Center·interventional·Posted Mar 5, 2013·Updated Sep 28, 2017

In Brief

A Phase 4 clinical trial evaluating Methadone and Morphine for Neonatal Abstinence Syndrome. Completed, enrolled 31 participants.

Detailed Summary

Hypothesis is that the effectiveness of opiate treatment with morphine will result in shorter duration of opiate medication treatment and fewer infants treated with a second drug.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNeonatal Abstinence Syndrome
Countries--
Collaborators--

Timeline

Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedMar 5, 2013
Enrollment StartJan 1, 2011
Primary CompletionOct 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 13.3 years ago

Interventions

Methadonedrug

To compare the duration of opiate medication treatment for babies on methadone versus those on morphine.

Morphinedrug

To compare the duration of opiate medication treatment for babies on methadone versus those on morphine.